FMT
DYN icon

First Mercantile Trust’s Dyne Therapeutics DYN Stock Holding History

First Mercantile Trust’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$49K Sell
3,007
-1,010
-25% -$17.9K 0.01% 778
2021
Q2 		$85K Sell
4,017
-531
-12% -$9.98K 0.01% 726
2021
Q1 		$71K Buy
4,548
+1,904
+72% +$36.8K 0.01% 740
2020
Q4 		$56K Buy
+2,644
New +$52.3K 0.01% 776

Other funds holding DYN

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

First Mercantile Trust's DYN Position: Q3 2021 in Review

First Mercantile Trust reduced its Dyne Therapeutics (DYN) stake by 25% in Q3 2021, selling an estimated $17.9K and leaving 3,007 shares worth $49K. The position accounts for 0.01% of the portfolio, ranked #778.

First Mercantile Trust first reported a position in DYN in Q4 2020 and has held it in 4 quarters since. The position peaked at $85K in Q2 2021. 83 funds tracked by Wall St. Rank hold DYN as of Q3 2021.

  • First Mercantile Trust held 3,007 shares of Dyne Therapeutics worth $49K as of Q3 2021.
  • First Mercantile Trust sold 1,010 Dyne Therapeutics shares in Q3 2021, an estimated $17.9K.
  • Dyne Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #778 holding.
  • First Mercantile Trust first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • First Mercantile Trust's Dyne Therapeutics position peaked at $85K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.